Boston Scientific Corporation has announced results from a pooled analysis of patients from its TAXUS IV and TAXUS V randomised clinical trials to compare the safety and efficacy of the TAXUS Express Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients.
Despite Hurricane Amma storming over Prague, hundreds of medical specialists paid little attention when they attended the 1st International Conference on Advanced Technologists and Treatments for Diabetes (ATTD), observed our Russian correspondent Olga Ostrovskaya, reporting on the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Prague (ATTD) held in…
'How do you treat the HIV-positive, diabetic, schizophrenic patient presenting with chest pain? By making the necessary information available for personalised medicine'
By Professor Jean-Charles Preiser MD PhD, of the Department of General Intensive Care, University Hospital Centre, University of Liege, Belgium
Type 2 diabetes poses one of the greatest public health threats of the 21st century. The majority of the western world is in the grips of a diabetes epidemic driven by type 2 diabetes that goes hand in hand with the escalating incidence of obesity. Alarmingly, in some working class and poor communities, the disease is so prevalent that its victims almost take it as a matter of course.
Presented during a symposium at Langenbeck-Virchow-Haus, in Berlin, the European CLINICIP research project aims to develop a method to improve glycaemic control during intensive care and provide a low-risk monitoring and control system that can control the metabolism of the critically ill
Heidelberger-Medical-Marketing GmbH (HMM) presented the first CE-Certified and EU-Registered blood glucose meter for self-monitoring with Bluetooth technology, the smartLABgenie at Medica on Wednesday.
Enzymes are biocatalysts that control the different metabolic processes of living organisms. These range from digestion to the copying of genetic information.
The DCA Vantage Analyser from Siemens Medical Solutions Diagnostics is a user-friendly, point-of-care (POC) patient management platform for diabetes.
Professor Oliver Schnell, of the Diabetes Research Institute, Munich, reports on discussions and findings of a panel of diabetes experts who met this summer in Switzerland
The results of the blood pressure lowering arm of the ADVANCE (Action in Diabetes and Vascular Disease) study, the largest ever trial conducted in people with type 2 diabetes, were recently reported in the Lancet.
In Europe, more than ten million people suffer from diabetes mellitus, 90 percent of whom have diabetes type II.
"If you think 53 makes you old enough to retire, then fine, go ahead and retire. But don't expect the state to pay for it." President Nicolas Sarkozy, during his election campaign
Omega-3 may protect children at high risk of developing type 1 diabetes, according to a study published in the Journal of the American Medical Association.
The first wireless POC (Point of care) blood glucose and bedside testing solution for hospitals was launched by Bayer Healthcare during the 43rd Annual Meeting of the European Association for the Study of Diabetes (EASD) in Amsterdam this September.
Michael Hall outlines the work and aims of IMAGE - the Development and Implementation of a European Guideline and Training Standards for Diabetes Prevention
Born in 1891, Canadian Sir Frederick Banting was destined to become a medical scientist and Nobel Prize winner for work that led to the discovery of insulin. World Diabetes Day, held on his birthday, aims to sensitise the public - including potential patients - to this condition. Worldwide, around 245 million people suffer Diabetes mellitus. With 5.3 million of them in Germany, the country's…
The Glide Solid Dose Injector (SDI), the needle-free drug delivery system that injects drugs in solid dosage form into the skin, has contributed to its manufacturer, Glide Pharma, winning the Best Business Award at the 2007 Medical Futures Innovation Awards.
Diabetic foot syndrome (DFS) is one of the most serious sequela of diabetes mellitus - Disease management programmes (DMP) yield first results
The aortocoronary bypass is an important surgical method for multivessel coronary revascularization, especially in the presence of complex lesions and in diabetic patients. It is can improve the prognosis of patients with three vessel disease and with left ventricular dysfunction1 . With regard to the type of graft used, bypasses are split into venous and arterial types. The use of venous…
The World Health Organisation (WHO) quotes figures that indicate there are over one billion overweight adults spread across the world, as of 2007, with at least 300 million of these defined as clinically obese (as defined by a BMI (body mass index) of 30).
By Henning von Eicke of Roche Diagnostics GmbH
The first, pan-European guidelines to be published on the treatment of valvular heart disease (VHD), diabetes and cardiovascular diseases (CVD) have made a series of new recommendations that experts hope will contribute to improving the outcome for patients.
Preliminary findings from the largest-ever study of treatments for diabetes provide no evidence that intensive treatment to lower blood glucose (sugar) increases risk of death.
Affordable, effective and innovative products drive sales.
